158 results on '"Artioli, Grazia"'
Search Results
2. Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study
- Author
-
Tuninetti, Valentina, Virano, Elisa, Salutari, Vanda, Ricotti, Andrea, Pisano, Carmela, Ducceschi, Monika, Turitto, Giacinto, Scandurra, Giuseppa, Petrella, Maria Cristina, Forestieri, Valeria, Rizzetto, Monica, Mammoliti, Serafina, Artioli, Grazia, Cioffi, Raffaella, Borsotti, Lucia, Bellero, Marco, Rognone, Chiara, Carbone, Vittoria, Ferrandina, Gabriella, Mantiero, Mara, Azzolina, Carmen, Geninatti, Eleonora, Pignata, Sandro, and Valabrega, Giorgio
- Published
- 2024
- Full Text
- View/download PDF
3. Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study
- Author
-
O'Cearbhaill, Roisin E., Pérez-Fidalgo, Jose-Alejandro, Monk, Bradley J., Tusquets, Ignacio, McCormick, Colleen, Fuentes, Jose, Moore, Richard G., Vulsteke, Christof, Shahin, Mark S., Forget, Frédéric, Bradley, William H., Hietanen, Sakari, O'Malley, David M., Dørum, Anne, Slomovitz, Brian M., Baumann, Klaus, Selle, Frédéric, Calvert, Paula M., Artioli, Grazia, Levy, Tally, Kumar, Aalok, Malinowska, Izabela A., Li, Yong, Gupta, Divya, and González-Martín, Antonio
- Published
- 2022
- Full Text
- View/download PDF
4. Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial.
- Author
-
Indraccolo, Stefano, Signoriello, Simona, Piga, Ilaria, Esposito, Giovanni, Ferrarini, Federica, Boscolo Bragadin, Andrea, Salutari, Vanda, Pisano, Carmela, Califano, Daniela, Bignotti, Eliana, Tognon, Germana, Simeon, Vittorio, Artioli, Grazia, Ferrero, Annamaria, Cinieri, Saverio, Bologna, Alessandra, Chiodini, Paolo, Scognamiglio, Giosuè, Bottoni, Carolina, and Spina, Anna
- Published
- 2024
- Full Text
- View/download PDF
5. Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial
- Author
-
Di Liello, Raimondo, Arenare, Laura, Raspagliesi, Francesco, Scambia, Giovanni, Pisano, Carmela, Colombo, Nicoletta, Frezzini, Simona, Tognon, Germana, Artioli, Grazia, Gadducci, Angiolo, Lauria, Rossella, Ferrero, Annamaria, Cinieri, Saverio, De Censi, Andrea, Breda, Enrico, Scollo, Paolo, De Giorgi, Ugo, Lissoni, Andrea Alberto, Katsaros, Dionyssios, Lorusso, Domenica, Salutari, Vanda, Cecere, Sabrina Chiara, Lapresa, Mariateresa, Nardin, Margherita, Bogani, Giorgio, Distefano, Mariagrazia, Greggi, Stefano, Gargiulo, Piera, Schettino, Clorinda, Gallo, Ciro, Daniele, Gennaro, Califano, Daniela, Perrone, Francesco, Pignata, Sandro, and Piccirillo, Maria Carmela
- Published
- 2021
- Full Text
- View/download PDF
6. Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey
- Author
-
Cioffi, Raffaella, Sabetta, Giulia, Rabaiotti, Emanuela, Bergamini, Alice, Bocciolone, Luca, Candotti, Giorgio, Candiani, Massimo, Valabrega, Giorgio, Mangili, Giorgia, Pignata, Sandro, Sambataro, Daniela, Mammoliti, Serafina, Breda, Enrico, D’Alessio, Antonietta, Rondello, Giacomo, Arcangeli, Valentina, Messina, Carlo, Artioli, Grazia, Maneschi, Francesco, Andreetta, Claudia, Raspagliesi, Francesco, Stefano, Aida Di, Ditto, Antonino, Garassino, Isabella Maria Giovanna, Carella, Claudia, Ferrandina, Maria Gabriella, Narducci, Filomena, Cirigliano, Giovanna, Corrado, Giacomo, Borghesi, Simona, Legge, Francesco, Bartoletti, Michele, De Giorgi, Ugo, Festi, Anna, Ronzino, Graziana, Scandurra, Giusy, Kardhashi, Anila, Zamagni, Claudio, Petrella, Maria Cristina, Mosconi, Anna Maria, Pinto, Giancarlo Di, Savarese, Antonella, Perin, Alessandra, Palma, Teresa Di, Rubino, Daniela, Zanaboni, Flavia, Vertechy, Laura, Roccio, Marianna, Palaia, Innocenza, Giovannoni, Sara, Cassani, Chiara, Sergi, Domenico, Scotto, Giulia, Lauria, Rossella, Perrone, Anna Myriam, Danese, Saverio, and Scarfone, Giovanna
- Published
- 2021
- Full Text
- View/download PDF
7. Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study
- Author
-
Daniele, Gennaro, Raspagliesi, Francesco, Scambia, Giovanni, Pisano, Carmela, Colombo, Nicoletta, Frezzini, Simona, Tognon, Germana, Artioli, Grazia, Gadducci, Angiolo, Lauria, Rossella, Ferrero, Annamaria, Cinieri, Saverio, De Censi, Andrea, Breda, Enrico, Scollo, Paolo, De Giorgi, Ugo, Lissoni, Andrea Alberto, Katsaros, Dionyssios, Lorusso, Domenica, Salutari, Vanda, Cecere, Sabrina Chiara, Zaccarelli, Eleonora, Nardin, Margherita, Bogani, Giorgio, Distefano, Mariagrazia, Greggi, Stefano, Piccirillo, Maria Carmela, Fossati, Roldano, Giannone, Gaia, Arenare, Laura, Gallo, Ciro, Perrone, Francesco, and Pignata, Sandro
- Published
- 2021
- Full Text
- View/download PDF
8. Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21)
- Author
-
Artioli, Grazia, Giannone, Gaia, Valabrega, Giorgio, Maggiorotto, Furio, Genta, Sofia, Pignata, Sandro, Lorusso, Domenica, Cormio, Gennaro, Scalone, Simona, Nicoletto, Maria Ornella, Greco, Filippo, Rossi, Emanuela, Spagnoletti, Ilaria, De Giorgi, Ugo, Orditura, Michele, Mosconi, Anna Maria, Kardhashi, Anila, Bogliolo, Stefano, and Borgato, Lucia
- Published
- 2021
- Full Text
- View/download PDF
9. Multiorgan failure caused by pembrolizumab and axitinib in a woman affected by metastatic clear cell renal cell carcinoma: A case report and literature review
- Author
-
Di Marco, Andrea, primary, Artioli, Grazia, additional, Favaretto, Adolfo, additional, Cavasin, Nicolò, additional, and Basso, Umberto, additional
- Published
- 2024
- Full Text
- View/download PDF
10. Genetic And Immunohistochemical Analysis In Endometrial Carcinoma: First Results On 153 Patients Of An Open Retrospective Study
- Author
-
Kilzie, Sami, Corrao, Giuseppa, Artioli, Grazia, Gava, Stefano, Salmeri, Maria Grazia, Griseri, Mara, Vinci, Mattia, De Santis, Michela, Mazzotta, Antonio, Bernardini, Valentina, Buttafuoco, Andrea, Piva, Isabella, and Busato, Enrico
- Published
- 2025
- Full Text
- View/download PDF
11. Niraparib In Patients With No Residual Disease After Primary Surgery: Preliminary Results Of The MITO 40 Study
- Author
-
Di Napoli, Marilena, Ferrandina, Gabriella, Scambia, Giovanni, Coppola, Elisabetta, Vertechy, Laura, Cassani, Chiara, Catania, Giovanna, Corsetti, Serena, Abeni, Chiara, Ortega, Cinzia, Ducceschi, Monika, Luvero, Daniela, Petrella, Maria Cristina, Elia, Maria Teresa, Sabbatini, Roberto, Tasca, Giulia, Tognon, Germana, Artioli, Grazia, Zamagni, Claudio, and Pignata, Sandro
- Published
- 2025
- Full Text
- View/download PDF
12. The Role Of POLE Mutational Status In Endometrial Cancer: A MITO POLE-END Observational Study
- Author
-
Artioli, Grazia, Giannarelli, Diana, Cavasin, Nicolo, Restaino, Stefano, Fruscio, Robert, Legge, Francesco, Baldoni, Alessandra, Cassani, Chiara, Alberto, Daniele, Mancari, Rosanna, Chiari, Rita, D'Asta, Marco, Amico, Paolo, Carella, Claudia, Pisano, Carmen, Tuninetti, Valentina, and Frezzini, Simona
- Published
- 2025
- Full Text
- View/download PDF
13. Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial
- Author
-
Lorusso, Domenica, primary, Raspagliesi, Francesco, additional, Ronzulli, Dominique, additional, Valabrega, Giorgio, additional, Colombo, Nicoletta, additional, Pisano, Carmen, additional, Cassani, Chiara, additional, Tognon, Germana, additional, Tamberi, Stefano, additional, Mangili, Giorgia, additional, Mammoliti, Serafina, additional, De Giorgi, Ugo, additional, Greco, Filippo, additional, Mosconi, Anna Maria, additional, Breda, Enrico, additional, Artioli, Grazia, additional, Andreetta, Claudia, additional, Casanova, Claudia, additional, Ceccherini, Rita, additional, Frassoldati, Antonio, additional, Salutari, Vanda, additional, Giolitto, Serena, additional, and Scambia, Giovanni, additional
- Published
- 2024
- Full Text
- View/download PDF
14. Corrigendum: Management of metastatic endometrial cancer: physicians’ choices beyond the first line after approval of checkpoint inhibitors
- Author
-
Arezzo, Francesca, primary, Giannone, Gaia, additional, Castaldo, Daniele, additional, Scotto, Giulia, additional, Tuninetti, Valentina, additional, Turinetto, Margherita, additional, Bartoletti, Michele, additional, Mammoliti, Serafina, additional, Artioli, Grazia, additional, Mangili, Giorgia, additional, Salutari, Vanda, additional, Lorusso, Domenica, additional, Cormio, Gennaro, additional, Loizzi, Vera, additional, Zamagni, Claudio, additional, Savarese, Antonella, additional, Di Maio, Massimo, additional, Ronzino, Graziana, additional, Pisano, Carmela, additional, Pignata, Sandro, additional, and Valabrega, Giorgio, additional
- Published
- 2024
- Full Text
- View/download PDF
15. PARP Inhibitors in Brain Metastases from Epithelial Ovarian Cancer through a Multimodal Patient Journey: Case Reports and Literature Review.
- Author
-
Frezzini, Simona, Tasca, Giulia, Borgato, Lucia, Sartor, Lucia, Ferrero, Annamaria, Artioli, Grazia, Modena, Alessandra, and Baldoni, Alessandra
- Subjects
OVARIAN epithelial cancer ,BRAIN metastasis ,POLY(ADP-ribose) polymerase ,FALLOPIAN tubes ,ARACHNOID cysts ,CENTRAL nervous system - Abstract
Epithelial ovarian cancer (EOC) is the deadliest gynecological malignancy worldwide. Brain metastasis (BM) is quite an uncommon presentation. However, the likelihood of central nervous system (CNS) metastasization should be considered in the context of disseminated disease. The therapeutic management of BMs is an unmet clinical need, to date. We identified, across different cancer centers, six cases of both BRCA wild-type and BRCA-mutated EOCs spreading to the CNS. They presented either with a single brain lesion or with multiple lesions and most of them had intracranial-only disease. All cases received Poly-ADP ribose polymerase inhibitor (PARPi) maintenance, as per clinical practice, for a long time within a multimodal treatment approach. We also provide an insight into the available body of work regarding the management of this intriguing disease setting, with a glimpse of future therapeutic challenges. Despite the lack of unanimous guidelines, multimodal care pathways should be encouraged for the optimal disease control of this unfortunate patient subset. Albeit not being directly investigated in BM patients, PARPi maintenance is deemed to have a valuable role in this setting. Prospective research, aimed to implement worthwhile strategies in the multimodal patient journey of BMs from EOC, is eagerly awaited. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study
- Author
-
Turinetto, Margherita, primary, Ricotti, Andrea, additional, Marchetti, Claudia, additional, Pisano, Carmela, additional, Zamagni, Claudio, additional, Cassani, Chiara, additional, Malaguti, Paola, additional, Baldoni, Alessandra, additional, Scollo, Paolo, additional, Scandurra, Giuseppa, additional, Parisi, Alessandro, additional, Artioli, Grazia, additional, Palaia, Innocenza, additional, Vertechy, Laura, additional, Bergamini, Alice, additional, Picardo, Elisa, additional, Tuninetti, Valentina, additional, Scotto, Giulia, additional, Scambia, Giovanni, additional, Pignata, Sandro, additional, and Valabrega, Giorgio, additional
- Published
- 2023
- Full Text
- View/download PDF
17. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
- Author
-
McCormack, Mary, Whitmarsh, Karen, Allerton, Rozenn, Gregory, Deborah, Symonds, Paul, Hoskin, Peter J., Adusumalli, Madhavi, Anand, Anjana, Wade, Robert, Stewart, Alexandra, Taylor, Wendy, Kruitwagen, Roy F.P.M., Hollema, Harry, Pras, Elizabeth, Snyers, An, Stalpers, Lukas, Jobsen, Jan J., Slot, Annerie, Mens, Jan-Willem M., Stam, Tanja C., Van Triest, Baukelien, Van der Steen - Banasik, Elzbieta M., De Winter, Karin A.J., Quinn, Michael A., Kolodziej, Ilka, Pyman, Jan, Johnson, Carol, Capp, Anne, Fossati, Roldano, Gribaudo, Sergio, Lissoni, Andrea A., Ferrero, Annamaria, Artioli, Grazia, Davidson, Cathy, McLachlin, C. Meg, Ghatage, Prafull, Rittenberg, Paula V.C., Souhami, Luis, Thomas, Gillian, Duvillard, Pierre, Berton-Rigaud, Dominique, Tubiana-Mathieu, Nicole, de Boer, Stephanie M, Powell, Melanie E, Mileshkin, Linda, Katsaros, Dionyssios, Bessette, Paul, Haie-Meder, Christine, Ottevanger, Petronella B, Ledermann, Jonathan A, Khaw, Pearly, Colombo, Alessandro, Fyles, Anthony, Baron, Marie-Helene, Jürgenliemk-Schulz, Ina M, Kitchener, Henry C, Nijman, Hans W, Wilson, Godfrey, Brooks, Susan, Carinelli, Silvestro, Provencher, Diane, Hanzen, Chantal, Lutgens, Ludy C H W, Smit, Vincent T H B M, Singh, Naveena, Do, Viet, D'Amico, Romerai, Nout, Remi A, Feeney, Amanda, Verhoeven-Adema, Karen W, Putter, Hein, and Creutzberg, Carien L
- Published
- 2018
- Full Text
- View/download PDF
18. Management of metastatic endometrial cancer: physicians’ choices beyond the first line after approval of checkpoint inhibitors
- Author
-
Arezzo, Francesca, primary, Giannone, Gaia, additional, Castaldo, Daniele, additional, Scotto, Giulia, additional, Tuninetti, Valentina, additional, Turinetto, Margherita, additional, Bartoletti, Michele, additional, Mammoliti, Serafina, additional, Artioli, Grazia, additional, Mangili, Giorgia, additional, Salutari, Vanda, additional, Lorusso, Domenica, additional, Cormio, Gennaro, additional, Loizzi, Vera, additional, Zamagni, Claudio, additional, Savarese, Antonella, additional, Di Maio, Massimo, additional, Ronzino, Graziana, additional, Pisano, Carmela, additional, Pignata, Sandro, additional, and Valabrega, Giorgio, additional
- Published
- 2023
- Full Text
- View/download PDF
19. Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial
- Author
-
Daniele, Gennaro, Lorusso, Domenica, Scambia, Giovanni, Cecere, Sabrina C., Nicoletto, Maria Ornella, Breda, Enrico, Colombo, Nicoletta, Artioli, Grazia, Cannella, Lucia, Lo Re, Giovanni, Raspagliesi, Francesco, Maltese, Giuseppa, Salutari, Vanda, Ferrandina, Gabriella, Greggi, Stefano, Baldoni, Alessandra, Bergamini, Alice, Piccirillo, Maria Carmela, Tognon, Germana, Floriani, Irene, Signoriello, Simona, Perrone, Francesco, and Pignata, Sandro
- Published
- 2017
- Full Text
- View/download PDF
20. A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma
- Author
-
Gadducci, Angiolo, Grosso, Federica, Scambia, Giovanni, Raspagliesi, Francesco, Colombo, Nicoletta, Grignani, Giovanni, Casali, Paolo, Sanfilippo, Roberta, Buonadonna, Angela, Santoro, Armando, Bruzzone, Milena, Artioli, Grazia, Lorusso, Domenica, Biagioli, Elena, Fossati, Roldano, Galli, Francesca, Negri, Emanuele, Rulli, Eliana, Torri, Valter, and D’Incalci, Maurizio
- Published
- 2018
- Full Text
- View/download PDF
21. The Revolution of Immunotherapy in Gynecological Cancers: The Lazarus Effect in Endometrial Cancer
- Author
-
Ducceschi, Monika, primary, Polignano, Maggie, additional, Bini, Marta, additional, Lopez, Salvatore, additional, Conca, Elena, additional, Tamborini, Elena, additional, Perrone, Federica, additional, Carlo Stella, Giulia, additional, Petrella, Maria Cristina, additional, Carciotto, Rosaria, additional, Artioli, Grazia, additional, Maffeis, Valeria, additional, Sartor, Lucia, additional, Raspagliesi, Francesco, additional, and Mantiero, Mara, additional
- Published
- 2023
- Full Text
- View/download PDF
22. Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study
- Author
-
Colombo, Nicoletta, primary, Gadducci, Angiolo, additional, Landoni, Fabio, additional, Lorusso, Domenica, additional, Sabbatini, Roberto, additional, Artioli, Grazia, additional, Berardi, Rossana, additional, Ceccherini, Rita, additional, Cecere, Sabrina Chiara, additional, Cormio, Gennaro, additional, De Angelis, Carmine, additional, Legge, Francesco, additional, Lissoni, Andrea, additional, Mammoliti, Serafina, additional, Mangili, Giorgia, additional, Naglieri, Emanuele, additional, Petrella, Maria Cristina, additional, Ricciardi, Giuseppina Rosaria Rita, additional, Ronzino, Graziana, additional, Salutari, Vanda, additional, Sambataro, Daniela, additional, Savarese, Antonella, additional, Scandurra, Giuseppa, additional, Tasca, Giulia, additional, Tomao, Federica, additional, Valabrega, Giorgio, additional, Zavallone, Laura, additional, and Pignata, Sandro, additional
- Published
- 2023
- Full Text
- View/download PDF
23. Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study
- Author
-
Colombo, N, Gadducci, A, Landoni, F, Lorusso, D, Sabbatini, R, Artioli, G, Berardi, R, Ceccherini, R, Cecere, S, Cormio, G, De Angelis, C, Legge, F, Lissoni, A, Mammoliti, S, Mangili, G, Naglieri, E, Petrella, M, Ricciardi, G, Ronzino, G, Salutari, V, Sambataro, D, Savarese, A, Scandurra, G, Tasca, G, Tomao, F, Valabrega, G, Zavallone, L, Pignata, S, Colombo, Nicoletta, Gadducci, Angiolo, Landoni, Fabio, Lorusso, Domenica, Sabbatini, Roberto, Artioli, Grazia, Berardi, Rossana, Ceccherini, Rita, Cecere, Sabrina Chiara, Cormio, Gennaro, De Angelis, Carmine, Legge, Francesco, Lissoni, Andrea, Mammoliti, Serafina, Mangili, Giorgia, Naglieri, Emanuele, Petrella, Maria Cristina, Ricciardi, Giuseppina Rosaria Rita, Ronzino, Graziana, Salutari, Vanda, Sambataro, Daniela, Savarese, Antonella, Scandurra, Giuseppa, Tasca, Giulia, Tomao, Federica, Valabrega, Giorgio, Zavallone, Laura, Pignata, Sandro, Colombo, N, Gadducci, A, Landoni, F, Lorusso, D, Sabbatini, R, Artioli, G, Berardi, R, Ceccherini, R, Cecere, S, Cormio, G, De Angelis, C, Legge, F, Lissoni, A, Mammoliti, S, Mangili, G, Naglieri, E, Petrella, M, Ricciardi, G, Ronzino, G, Salutari, V, Sambataro, D, Savarese, A, Scandurra, G, Tasca, G, Tomao, F, Valabrega, G, Zavallone, L, Pignata, S, Colombo, Nicoletta, Gadducci, Angiolo, Landoni, Fabio, Lorusso, Domenica, Sabbatini, Roberto, Artioli, Grazia, Berardi, Rossana, Ceccherini, Rita, Cecere, Sabrina Chiara, Cormio, Gennaro, De Angelis, Carmine, Legge, Francesco, Lissoni, Andrea, Mammoliti, Serafina, Mangili, Giorgia, Naglieri, Emanuele, Petrella, Maria Cristina, Ricciardi, Giuseppina Rosaria Rita, Ronzino, Graziana, Salutari, Vanda, Sambataro, Daniela, Savarese, Antonella, Scandurra, Giuseppa, Tasca, Giulia, Tomao, Federica, Valabrega, Giorgio, Zavallone, Laura, and Pignata, Sandro
- Abstract
Introduction: Standard treatment of newly diagnosed, advanced ovarian carcinoma (OC) consists of cytoreductive surgery followed by platinum-based chemotherapy with or without bevacizumab. Maintenance therapy with PARP inhibitors and olaparib-bevacizumab has recently shown to significantly improve progression-free survival in the first-line setting. Some practical aspects of maintenance therapy, however, are still poorly defined. Aim of the study: To provide guidance to clinicians in the selection of maintenance therapy for newly diagnosed, advanced ovarian carcinoma. Methods: A board of six gynecologic oncologists with expertise in the treatment of OC in Italy convened to address issues related to the new options for maintenance treatment. Based on scientific evidences, the board produced practice-oriented statements. Consensus was reached via a modified Delphi study that involved a panel of 22 experts from across Italy. Results: Twenty-seven evidence- and consensus-based statements are presented, covering the following areas of interest: use of biomarkers (BRCA mutations and presence of homologous recombination deficiency); timing and outcomes of surgery; selection of patients eligible for bevacizumab; definition of response to treatment; toxicity and contraindications; evidence of synergy of bevacizumab plus PARP inhibitor. Two treatment algorithms are also included, for selecting maintenance therapy based on timing and outcomes of surgery, response to platinum-based chemotherapy and biomarker status. A score for the assessment of response to chemotherapy is proposed, but its validation is ongoing. Conclusions: We provide here consensus statements and treatment algorithms to guide clinicians in the selection of appropriate and personalized maintenance therapy in the first-line setting of advanced OC management.
- Published
- 2023
24. Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.
- Author
-
Arezzo, Francesca, Giannone, Gaia, Castaldo, Daniele, Scotto, Giulia, Tuninetti, Valentina, Turinetto, Margherita, Bartoletti, Michele, Mammoliti, Serafina, Artioli, Grazia, Mangili, Giorgia, Salutari, Vanda, Lorusso, Domenica, Cormio, Gennaro, Loizzi, Vera, Zamagni, Claudio, Savarese, Antonella, Di Maio, Massimo, Ronzino, Graziana, Pisano, Carmela, and Pignata, Sandro
- Subjects
ENDOMETRIAL cancer ,PHYSICIANS ,IMMUNE checkpoint inhibitors ,METASTASIS ,OVARIAN cancer ,THERAPEUTICS ,IPILIMUMAB ,PEMETREXED - Abstract
Introduction: Endometrial cancer (EC) represents 3.4% of all newly diagnosed cancer cases and is responsible for 2.1% of all cancer-related deaths. Approximately 10%-15% of women with EC are diagnosed with advancedstage disease, resulting in a reported 5-year survival rate of only 17% for those with distant metastases. A better understanding of its molecular features has ushered in a new era of immunotherapy for the treatment of EC, allowing for alternative therapeutic approaches, even in cases of advanced disease. Methods: We administered a multi-choice online survey for Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies (MITO) members. The questionnaire was available for 2 months, starting in October 2022. Our objective was to evaluate the current attitude of incorporating molecular characterization of EC into routine clinical practice, appraise the implementation of newly available therapies, and compare the outcomes with the previous survey conducted in April-May 2021 to ascertain the actual changes that have transpired during this recent time period. Results: The availability of molecular classification in Italian centers has changed in 1 year. Seventy-five percent of centers performed the molecular classification compared with 55.6% of the previous survey. Although this percentage has increased, only 18% performed all the tests. Significant changes have occurred in the administration of new treatments in EC patients in MITO centers. In 2022, 82.1% of the centers administrated dostarlimab in recurrent or advanced MMRdeficient (dMMR) EC experiencing disease progression after platinum-based chemotherapy regimens, compared to only 24.4% in 2021. In 2022, 85.7% of the centers already administrated the pembrolizumab plus lenvatinib combination as a second-line therapy for MMR-proficient (pMMR) patients with advanced or recurrent EC who had progressed from first-line platinumbased therapy. Conclusion: Both the therapeutic and diagnostic scenarios have changed over the last couple of years in MITO centers, with an increased prescription of immune checkpoint inhibitors and use of the molecular classification. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study
- Author
-
Turinetto, Margherita, Ricotti, Andrea, Marchetti, Claudia, Pisano, Carmela, Zamagni, Claudio, Cassani, Chiara, Malaguti, Paola, Baldoni, Alessandra, Scollo, Paolo, Scandurra, Giuseppa, Parisi, Alessandro, Artioli, Grazia, Palaia, Innocenza, Vertechy, Laura, Bergamini, Alice, Picardo, Elisa, Tuninetti, Valentina, Scotto, Giulia, Scambia, Giovanni, and Pignata, Sandro
- Subjects
THERAPEUTIC use of antineoplastic agents ,DRUG efficacy ,RESEARCH ,DISEASE progression ,HAND-foot syndrome ,OVARIAN tumors ,SCIENTIFIC observation ,CONFIDENCE intervals ,DOXORUBICIN ,RESEARCH methodology ,CASE-control method ,RETROSPECTIVE studies ,GASTROINTESTINAL diseases ,PLATINUM ,BLOOD diseases ,DESCRIPTIVE statistics ,RESEARCH funding ,FATIGUE (Physiology) ,ENZYME inhibitors ,EVALUATION - Abstract
Simple Summary: This multicenter, retrospective analysis had the objective of comparing the efficacy of PLD-Trabectedin in patients who had already been treated with PARP-I (cases) before vs. PARPi-naïve patients (controls). Data from 166 patients were collected, composed of 109 cases and 57 controls. In total, 135 patients were included in our analyses, composing 46 controls and 89 cases. We found a median PFS of 11 months (95% IC 10–12) in the control group vs. 8 months (95% IC 6–9) in the case group (p value 0.0017). The clinical benefit rate was evaluated, with an HR for progression of 2.55 (1.28–5.06) for the case group (p value 0.008) persisting when adjusted for BRCA mutation. The study showed a statistically significant difference in terms of PFS, suggesting that a previous exposure to PARP-i might inhibit the efficacy of PLD-Trabectedin. Regarding tolerability, no remarkable disparity was noted. Objective: While PLD-Trabectedin is an approved treatment for relapsed platinum-sensitive ovarian cancer, its efficacy and tolerability has so far not been tested extensively in patients who progress after poly ADP-ribose polymerase inhibitor (PARPi) treatment. Methodology: This multicenter, retrospective analysis had the objective of comparing patients receiving PLD-Trabectedin after being treated with PARP-I (cases) with PARPi-naïve patients. Descriptive and survival analyses were performed for each group. Results: Data from 166 patients were collected, composed of 109 cases and 57 controls. In total, 135 patients were included in our analyses, composing 46 controls and 89 cases. The median PFS was 11 months (95% IC 10–12) in the control group vs. 8 months (95% IC 6–9) in the case group (p value 0.0017). The clinical benefit rate was evaluated, with an HR for progression of 2.55 (1.28–5.06) for the case group (p value 0.008), persisting when adjusted for BRCA and line with treatment. We compared hematological toxicity, gastro-intestinal toxicity, hand–foot syndrome (HFS), fatigue, and liver toxicity, and no statistically significant disparity was noted, except for HFS with a p value of 0.006. The distribution of G3 and G4 toxicities was also equally represented. Conclusion: The MITO39 study showed a statistically significant difference in terms of PFS, suggesting that previous exposure to PARPi might inhibit the efficacy of PLD-Trabectedin. Regarding tolerability, no remarkable disparity was noted; PLD-Trabectedin was confirmed to be a well-tolerated scheme in both groups. To our knowledge, these are the first data regarding this topic, which we deem to be of great relevance in the current landscape. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial
- Author
-
Pignata, Sandro, primary, Scambia, Giovanni, additional, Schettino, Clorinda, additional, Arenare, Laura, additional, Pisano, Carmela, additional, Lombardi, Davide, additional, De Giorgi, Ugo, additional, Andreetta, Claudia, additional, Cinieri, Saverio, additional, De Angelis, Carmine, additional, Priolo, Domenico, additional, Casanova, Claudia, additional, Rosati, Marta, additional, Greco, Filippo, additional, Zafarana, Elena, additional, Schiavetto, Ilaria, additional, Mammoliti, Serafina, additional, Cecere, Sabrina Chiara, additional, Salutari, Vanda, additional, Scalone, Simona, additional, Farolfi, Alberto, additional, Di Napoli, Marilena, additional, Lorusso, Domenica, additional, Gargiulo, Piera, additional, Califano, Daniela, additional, Russo, Daniela, additional, Spina, Anna, additional, De Cecio, Rossella, additional, Chiodini, Paolo, additional, Perrone, Francesco, additional, Accinno, Valentina, additional, Altavilla, Chiara, additional, Antonelli, Giovanna, additional, Artioli, Grazia, additional, Avola, Francesco, additional, Barbara, Bonifacio, additional, Barbato, Valentina, additional, Bartoletti, Michele, additional, Bevilacqua, Simona, additional, Bordonaro, Roberto, additional, Borghese, Oriana, additional, Buonfanti, Gaetano, additional, Camarda, Floriana, additional, Canzanella, Giuliana, additional, Carbone, Vittoria, additional, Carbone, Maria Rita, additional, Carlo Stella, Giulia, additional, Cassani, Chiara, additional, Castagna, Fabrizio, additional, Cattaneo, Monica, additional, Cinefra, Margherita, additional, Colombo, Nicoletta, additional, Corsetti, Serena, additional, Dall'Agata, Monia, additional, D'Amico, Maria, additional, Daniele, Gennaro, additional, De Marino, Elvira, additional, De Matteis, Giovanni, additional, De Placido, Sabino, additional, Del Bene, Gabriella, additional, Del Giudice, Antonia, additional, Del Monte, Francesca, additional, Del Sesto, Michele, additional, Donini, Maddalena, additional, Drudi, Giuliana, additional, Falcone, Gianluca, additional, Favaretto, Adolfo, additional, Ferrera, Giulia, additional, Florio, Manuela, additional, Forestieri, Valeria, additional, Gallo, Maria Stella, additional, Gallo, Ciro, additional, Garibaldi, Francesca, additional, Gerevini, Fabiana, additional, Ghizzoni, Viola, additional, Giganti, Maria Olga, additional, Gimigliano, Anna, additional, Giudice, Elena, additional, Gnocchi, Nicoletta, additional, Gravina, Adriano, additional, Greggi, Stefano, additional, Iaia, Maria Laura, additional, Ilardi, Annalisa, additional, Iovine, Gelsomina, additional, Ippoliti, Gabriella, additional, Irollo, Giulia, additional, Isidori, Ilenia, additional, Lapresa, Mariateresa, additional, Lavenia, Giuseppe, additional, Longhitano, Laura, additional, Lucia, Bortot, additional, Luzi, Gabriella, additional, Mariano, Sara, additional, Marino, Valentina, additional, Marrapese, Giovanna, additional, Martino, Marilena, additional, Matocci, Roberta, additional, Mazzoni, Enrica, additional, Mercuri, Daniela, additional, Mirto, Maria, additional, Mollo, Giovanna, additional, Montinaro, Abbondanza, additional, Moscatelli, Marta, additional, Mosconi, Anna Maria, additional, Musacchio, Lucia, additional, Nanni, Nicoletta, additional, Natalucci, Pamela, additional, Nicoloso, Milena Sabrina, additional, Orditura, Michele, additional, Parma, Gabriella Maria, additional, Passalacqua, Rodolfo, additional, Pelone, Michela, additional, Perri, Maria Teresa, additional, Perrucci, Bruno, additional, Piancastelli, Alessandra, additional, Piccirillo, Maria Carmela, additional, Piccolo, Antonio, additional, Pignata, Sandro, additional, Rapisardi, Stefania, additional, Ravaglia, Giorgia, additional, Ribecco, Teresa, additional, Ricci, Caterina, additional, Roccio, Marianna, additional, Romano, Fiorella, additional, Sambataro, Daniela, additional, Savio, Alfonso, additional, Sbriglia, Ada, additional, Scaffa, Cono, additional, Sergi, Concetta, additional, Sgandurra, Francesca, additional, Sorio, Roberto, additional, Stabile, Stefano, additional, Tabaro, Gianna, additional, Tambaro, Margherita, additional, Tamberi, Stefano, additional, Tecchiato, Angelica, additional, Trujillo, Angela Maria, additional, and Zaccarelli, Eleonora, additional
- Published
- 2023
- Full Text
- View/download PDF
27. Rare uterine cancer: Carcinosarcomas. Review from histology to treatment
- Author
-
Artioli, Grazia, Wabersich, Jacopo, Ludwig, Kathrin, Gardiman, Marina Paola, Borgato, Lucia, and Garbin, Franco
- Published
- 2015
- Full Text
- View/download PDF
28. sj-pdf-2-tmj-10.1177_03008916221146820 – Supplemental material for Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society
- Author
-
Milani, Andrea, Tuninetti, Valentina, Pignata, Sandro, Lorusso, Domenica, Castaldo, Daniele, De Giorgi, Ugo, Savarese, Antonella, Biglia, Nicoletta, Scandurra, Giuseppa, Mangili, Giorgia, Di Maio, Massimo, Turinetto, Margherita, Bellero, Marco, Mammoliti, Serafina, Testa, Silvia, Scotto, Giulia, Purro, Andrea, Artioli, Grazia, and Valabrega, Giorgio
- Subjects
Medicine - Abstract
Supplemental material, sj-pdf-2-tmj-10.1177_03008916221146820 for Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society by Andrea Milani, Valentina Tuninetti, Sandro Pignata, Domenica Lorusso, Daniele Castaldo, Ugo De Giorgi, Antonella Savarese, Nicoletta Biglia, Giuseppa Scandurra, Giorgia Mangili, Massimo Di Maio, Margherita Turinetto, Marco Bellero, Serafina Mammoliti, Silvia Testa, Giulia Scotto, Andrea Purro, Grazia Artioli and Giorgio Valabrega in Tumori Journal
- Published
- 2023
- Full Text
- View/download PDF
29. Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study
- Author
-
Colombo, Nicoletta, Gadducci, Angiolo, Landoni, Fabio, Lorusso, Domenica, Sabbatini, Roberto, Artioli, Grazia, Berardi, Rossana, Ceccherini, Rita, Cecere, Sabrina Chiara, Cormio, Gennaro, De Angelis, Carmine, Legge, Francesco, Lissoni, Andrea, Mammoliti, Serafina, Mangili, Giorgia, Naglieri, Emanuele, Petrella, Maria Cristina, Ricciardi, Giuseppina Rosaria Rita, Ronzino, Graziana, Salutari, Vanda, Sambataro, Daniela, Savarese, Antonella, Scandurra, Giuseppa, Tasca, Giulia, Tomao, Federica, Valabrega, Giorgio, Zavallone, Laura, Pignata, Sandro, Colombo, N, Gadducci, A, Landoni, F, Lorusso, D, Sabbatini, R, Artioli, G, Berardi, R, Ceccherini, R, Cecere, S, Cormio, G, De Angelis, C, Legge, F, Lissoni, A, Mammoliti, S, Mangili, G, Naglieri, E, Petrella, M, Ricciardi, G, Ronzino, G, Salutari, V, Sambataro, D, Savarese, A, Scandurra, G, Tasca, G, Tomao, F, Valabrega, G, Zavallone, L, and Pignata, S
- Subjects
Bevacizumab ,Olaparib ,PARP inhibitor ,HRD ,Advanced ovarian cancer ,BRCA ,Maintenance therapy ,Niraparib - Abstract
Introduction: Standard treatment of newly diagnosed, advanced ovarian carcinoma (OC) consists of cytoreductive surgery followed by platinum-based chemotherapy with or without bevacizumab. Maintenance therapy with PARP inhibitors and olaparib-bevacizumab has recently shown to significantly improve progression-free survival in the first-line setting. Some practical aspects of maintenance therapy, however, are still poorly defined. Aim of the study: To provide guidance to clinicians in the selection of maintenance therapy for newly diagnosed, advanced ovarian carcinoma. Methods: A board of six gynecologic oncologists with expertise in the treatment of OC in Italy convened to address issues related to the new options for maintenance treatment. Based on scientific evidences, the board produced practice-oriented statements. Consensus was reached via a modified Delphi study that involved a panel of 22 experts from across Italy. Results: Twenty-seven evidence- and consensus-based statements are presented, covering the following areas of interest: use of biomarkers (BRCA mutations and presence of homologous recombination deficiency); timing and outcomes of surgery; selection of patients eligible for bevacizumab; definition of response to treatment; toxicity and contraindications; evidence of synergy of bevacizumab plus PARP inhibitor. Two treatment algorithms are also included, for selecting maintenance therapy based on timing and outcomes of surgery, response to platinum-based chemotherapy and biomarker status. A score for the assessment of response to chemotherapy is proposed, but its validation is ongoing. Conclusions: We provide here consensus statements and treatment algorithms to guide clinicians in the selection of appropriate and personalized maintenance therapy in the first-line setting of advanced OC management.
- Published
- 2023
30. sj-pdf-1-tmj-10.1177_03008916221146820 – Supplemental material for Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society
- Author
-
Milani, Andrea, Tuninetti, Valentina, Pignata, Sandro, Lorusso, Domenica, Castaldo, Daniele, De Giorgi, Ugo, Savarese, Antonella, Biglia, Nicoletta, Scandurra, Giuseppa, Mangili, Giorgia, Di Maio, Massimo, Turinetto, Margherita, Bellero, Marco, Mammoliti, Serafina, Testa, Silvia, Scotto, Giulia, Purro, Andrea, Artioli, Grazia, and Valabrega, Giorgio
- Subjects
Medicine - Abstract
Supplemental material, sj-pdf-1-tmj-10.1177_03008916221146820 for Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society by Andrea Milani, Valentina Tuninetti, Sandro Pignata, Domenica Lorusso, Daniele Castaldo, Ugo De Giorgi, Antonella Savarese, Nicoletta Biglia, Giuseppa Scandurra, Giorgia Mangili, Massimo Di Maio, Margherita Turinetto, Marco Bellero, Serafina Mammoliti, Silvia Testa, Giulia Scotto, Andrea Purro, Grazia Artioli and Giorgio Valabrega in Tumori Journal
- Published
- 2023
- Full Text
- View/download PDF
31. Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study
- Author
-
Tuninetti, Valentina, primary, Ghisoni, Eleonora, additional, Pignata, Sandro, additional, Picardo, Elisa, additional, Raspagliesi, Francesco, additional, Andreetta, Claudia, additional, Maldi, Elena, additional, Artioli, Grazia, additional, Mammoliti, Serafina, additional, Zanchi, Lucia, additional, Sikokis, Angelica, additional, Biglia, Nicoletta, additional, Parisi, Alessandro, additional, Mandato, Vincenzo Dario, additional, Carella, Claudia, additional, Cormio, Gennaro, additional, Marinaccio, Marco, additional, Puppo, Andrea, additional, Paolini, Biagio, additional, Borsotti, Lucia, additional, Scotto, Giulia, additional, Turinetto, Margherita, additional, Sangiolo, Dario, additional, Di Maio, Massimo, additional, and Valabrega, Giorgio, additional
- Published
- 2023
- Full Text
- View/download PDF
32. Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society
- Author
-
Milani, Andrea, primary, Tuninetti, Valentina, additional, Pignata, Sandro, additional, Lorusso, Domenica, additional, Castaldo, Daniele, additional, De Giorgi, Ugo, additional, Savarese, Antonella, additional, Biglia, Nicoletta, additional, Scandurra, Giuseppa, additional, Mangili, Giorgia, additional, Di Maio, Massimo, additional, Turinetto, Margherita, additional, Bellero, Marco, additional, Mammoliti, Serafina, additional, Testa, Silvia, additional, Scotto, Giulia, additional, Purro, Andrea, additional, Artioli, Grazia, additional, and Valabrega, Giorgio, additional
- Published
- 2023
- Full Text
- View/download PDF
33. Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS)
- Author
-
Mercadante, Sebastiano, Marchetti, Paolo, Cuomo, Arturo, Caraceni, Augusto, Mediati, Rocco Domenico, Mammucari, Massimo, Natoli, Silvia, Lazzari, Marzia, Dauri, Mario, Airoldi, Mario, Azzarello, Giuseppe, Bandera, Mauro, Blasi, Livio, Cartenì, Giacomo, Chiurazzi, Bruno, Costanzo, Benedetta Veruska Pierpaola, Degiovanni, Daniela, Fusco, Flavio, Guardamagna, Vittorio, Iaffaioli, Vincenzo, Liguori, Simeone, Lorusso, Vito, Mameli, Sergio, Mattioli, Rodolfo, Mazzei, Teresita, Melotti, Rita Maria, Menardo, Valentino, Miotti, Danilo, Moroso, Stefano, De Santis, Stefano, Orsetti, Remo, Papa, Alfonso, Ricci, Sergio, Sabato, Alessandro Fabrizio, Scelzi, Elvira, Sofia, Michele, Tonini, Giuseppe, Aielli, Federica, Valle, Alessandro, Caruselli, Amanda, Prestia, Giovanna, Giusti, Raffaele, Costanzi, Andrea, Angelini, Silvia, Iacono, Daniela, Mazzuca, Federica, Carnevale, Alessia, Bonome, Paolo, Nicosia, Luca, Scaringi, Claudia, Montalto, Adelaide, Russo, Gennaro, Forte, Cira Antonietta, Esposito, Gennaro, Bracchi, Paola, Zecca, Ernesto, Campa, Tiziana, Grecchi, Silvia, Pigni, Alessandra, Sammaro, Annunziata, Dodaro, Lucia, Ballerini, Giovanna, Vellucci, Renato, Caldarulo, Clarissa, Palombo, Elisa, Diviza, Marco, Gianfelice, Valentina, Silvestri, Claudia, Finocchi, Simona, Contu, Viviana, Fora, Gianluca, Pedani, Fulvia, Icardi, Massimiliano, Bellini, Elisa, Celano, Alfredo, Berardo, Roberto, Ostellino, Oliviero, Sartori, Kayta, Demartini, Paola, Scroccaro, Raffaella, Boscolo, Giorgia, Sartori, Donata, Rosetti, Francesco, Artioli, Grazia, Borgato, Lucia, Bertoldero, Giovanni, Veronese, Barbara, Vallini, Ilaria, Tuzi, Alessandro, Bolzacchini, Elena, Pinotti, Graziella, Alù, Massimiliano, Usset, Antonella, Arcuri, Carmela, Laudani, Agata, Pepe, Alessio, Scagliarini, Sarah, Sgarlata, Massimiliano Savio Maria, Raimondi, Massimo, Valenti, Salvatore Maria Giovanni, Bucceri, Alberto, Kasa, Alma, Budel, Paola, Caramellino, Anna, Ballarino, Paola, Donelli, Emanuela, Silvestro, Stefania, Tonetti, Rossella, Bozzoni, Samuela, Cocquio, Angela, Romano, Carmela, Nappi, Anna, Silvestro, Lucrezia, De Divitiis, Chiara, Ghidoni, Silvia, Cortinovis, Rosalba, Marchesi, Roberta, Fortis, Michele, Palermo, Loredana, Pisanu, Giovanni Maria, Carboni, Maura, Meloni, Francesca, Barillari, Daniele, Imperatori, Luca, Grilli, Gianni, Laici, Gianluca, Diacciati, Sara, Petreni, Paolo, Samolsky Dekel, Boaz, Marsigli, Federica, Manfreda, Miriam, Ghedini, Silvia, Bruno, Emanuela, Salvini, Emanuele, Gerboni, Davide, Saulle, Serena, Carella, Roberta, Pascoletti, Gaetano, Bolzonello, Silvia, Bonotto, Marta, Ellero, Silvia, Fasola, Gianpiero, Ongaro, Elena, Borghesi, Cristina, Germani, Lucia, De Ruvo, Edoardo, Marchetti, Federica, Pasquale, Milena, Masu, Lucia, Tammaro, Dario, Saracco, Elisabetta, Di Dato, Maria Teresa, Ferrara, Maurizio, Pironti, Andrea, Buonavolontà, Pietro, Ginocchi, Laura, Musettini, Gianna, Antonuzzo, Andrea, Caparello, Chiara, Lucchesi, Maurizio, Farnesi, Azzurra, Zampieri, Mari, Pisciotta, Manuela, Fioroni, Iacopo, Ratta, Raffaele, Cursano, Maria Concetta, Santini, Daniele, Potestà, Cinzia, Gallo, Gloria, Saber, Benhaz, and On behalf of the IOPS MS study group
- Published
- 2017
- Full Text
- View/download PDF
34. 2022-RA-669-ESGO Perioperative management of advanced ovarian (tubal/peritoneal) cancer patients. a survey from MITO-ManGO Groups
- Author
-
Falcone, Francesca, primary, Gallo, Maria Stella, additional, Cascella, Marco, additional, Bifulco, Francesca, additional, Artioli, Grazia, additional, Cassandrini, Paola Agnese, additional, Casella, Gennaro, additional, Palma, Maurizia Dalla, additional, Falchi, Laura, additional, Scaffa, Cono, additional, Scala, Felice, additional, Visconti, Serena, additional, Laurelli, Giuseppe, additional, Grimaldi, Rosaria, additional, Formisano, Lucia, additional, Frassoldati, Antonio, additional, Cicinelli, Ettore, additional, Stola, Emilio, additional, Aletti, Giovanni Damiano, additional, and Greggi, Stefano, additional
- Published
- 2022
- Full Text
- View/download PDF
35. Randomized phase III trial on trabectedin (ET-743) single agent versus clinician’s choice chemotherapy in recurrent ovarian, primary peritoneal, or fallopian tube cancers of BRCA-mutated or BRCAness phenotype patients (MITO23).
- Author
-
Scambia, Giovanni, primary, Raspagliesi, Francesco, additional, Valabrega, Giorgio, additional, Colombo, Nicoletta, additional, Pisano, Carmen, additional, Cassani, Chiara, additional, Tognon, Germana, additional, Tamberi, Stefano, additional, Mangili, Giorgia, additional, Mammoliti, Serafina, additional, De Giorgi, Ugo, additional, Greco, Filippo, additional, Mosconi, Anna Maria, additional, Breda, Enrico, additional, Artioli, Grazia, additional, Andreetta, Claudia, additional, Casanova, Claudia, additional, Ceccherini, Rita, additional, Frassoldati, Antonio, additional, and Lorusso, Domenica, additional
- Published
- 2022
- Full Text
- View/download PDF
36. Management of Metastatic Endometrial Cancer: Physicians’ Choices Beyond the First Line. A MITO Survey
- Author
-
Giannone, Gaia, primary, Castaldo, Daniele, additional, Tuninetti, Valentina, additional, Scotto, Giulia, additional, Turinetto, Margherita, additional, Valsecchi, Anna Amela, additional, Bartoletti, Michele, additional, Mammoliti, Serafina, additional, Artioli, Grazia, additional, Mangili, Giorgia, additional, Salutari, Vanda, additional, Lorusso, Domenica, additional, Cormio, Gennaro, additional, Zamagni, Claudio, additional, Savarese, Antonella, additional, Di Maio, Massimo, additional, Ronzino, Graziana, additional, Pisano, Carmela, additional, Pignata, Sandro, additional, and Valabrega, Giorgio, additional
- Published
- 2022
- Full Text
- View/download PDF
37. Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers
- Author
-
Bradbury, Angela R., Ibe, Comfort N., Dignam, James J., Cummings, Shelly A., Verp, Marion, White, Melody A., Artioli, Grazia, Dudlicek, Laura, and Olopade, Olufunmilayo I.
- Published
- 2008
- Full Text
- View/download PDF
38. Combined use of biomarkers for detection of ovarian cancer in high-risk women
- Author
-
Donach, Martin, Yu, Yinhua, Artioli, Grazia, Banna, Giuseppe, Feng, Weiwei, Bast, Jr., Robert C., Zhang, Zhen, and Nicoletto, Maria O.
- Published
- 2010
- Full Text
- View/download PDF
39. Efficacy of niraparib by timing of surgery and residual disease: a post-hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study
- Author
-
O'Cearbhaill, Roisin, primary, Pérez-Fidalgo, Jose Alejandro, additional, Monk, Bradley, additional, Tusquets, Ignasi, additional, McCormick, Colleen, additional, Fuentes, Jose, additional, Moore, Richard, additional, Vulsteke, Christof, additional, Shahin, Mark, additional, Forget, Frédéric, additional, Bradley, William, additional, Hietanen, Sakari, additional, O'Malley, David, additional, Dørum, Anne, additional, Slomovitz, Brian, additional, Baumann, Klaus, additional, Selle, Frédéric, additional, Calvert, Paula, additional, Artioli, Grazia, additional, Levy, Tally, additional, Kumar, Aalok, additional, Malinowska, Izabela, additional, Li, Yong, additional, Gupta, Divya, additional, and González-Martín, Antonio, additional
- Published
- 2021
- Full Text
- View/download PDF
40. Is achievement of amenorrhea a desiderable side effect of breast cancer treatment in young premenopausal patients?: OP03
- Author
-
Baretta, Zora, Evangelista, Laura, Orvieto, Enrico, Lo Mele, Marcello, Ziampiri, Stamatia, Artioli, Grazia, Jirillo, Antonio, and Ghiotto, Cristina
- Published
- 2011
41. Knowledge and attitudes towards clinical trials among women with ovarian cancer: results of the ACTO study.
- Author
-
Mosconi, Paola, Roberto, Anna, Cerana, Nicoletta, Colombo, Nicoletta, Didier, Florence, D'Incalci, Maurizio, Lorusso, Domenica, Peccatori, Fedro Alessandro, Network of Clinicians and Participants (1), Artioli, Grazia, Cavanna, Luigi, Ceccherini, Rita, Cirigliano, Giovanna, Comerci, Giuseppe, Cormio, Gennaro, Crippa, Alessandra, Farolfi, Alberto, Febbraro, Antonio, Giardina, Donatella, and Greggi, Stefano
- Subjects
OVARIAN cancer ,CANCER patients ,CLINICAL trials ,GYNECOLOGIC oncology ,ATTITUDE (Psychology) ,MEDICAL communication - Abstract
Background: Despite several initiatives by research groups, regulatory authorities, and scientific associations to engage citizens/patients in clinical research, there are still obstacles to participation. Among the main discouraging aspects are incomplete understanding of the concepts related to a clinical trial, and the scant, sometimes confused, explanations given. This observational, cross-sectional multicenter study investigated knowledge, attitudes and trust in clinical research. We conducted a survey among women with ovarian cancer at their first follow-up visit or first therapy session, treated in centers belonging to the Mario Negri Gynecologic Oncology (MaNGO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groups. A questionnaire on knowledge, attitudes and experience was assembled ad hoc after a literature review and a validation process involving patients of the Alliance against Ovarian Cancer (ACTO). Results: From 25 centers 348 questionnaire were collected; 73.5% of responders were 56 years or older, 54.8% had a high level of education, more than 80% had no experience of trial participation. Among participants 59% knew what clinical trials were and 71% what informed consent was. However, more than half did not know the meaning of the term randomization. More than half (56%) were in favor of participating in a clinical trial, but 35% were not certain. Almost all responders acknowledged the doctor's importance in decision-making. Patients' associations were recognized as having a powerful role in the design and planning of clinical trials. Conclusions: This study helps depict the knowledge and attitudes of women with ovarian cancer in relation to clinical trials, suggesting measures aimed at improving trial "culture", literacy and compliance, and fresh ways of communication between doctors and patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
42. Treatment of Recurrent Endometrial Cancer: Chemotherapy, Hormonal Therapy, and Radiotherapy
- Author
-
Mundt, Arno J., primary, Artioli, Grazia, additional, and Fleming, Gini F., additional
- Published
- 2004
- Full Text
- View/download PDF
43. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness
- Author
-
Patel, Vivek L., Busch, Evan L., Friebel, Tara M., Cronin, Angel, Leslie, Goska, McGuffog, Lesley, Adlard, Julian, Agata, Simona, Agnarsson, Bjarni A., Ahmed, Munaza, Aittomaki, Kristiina, Alducci, Elisa, Andrulis, Irene L., Arason, Adalgeir, Arnold, Norbert, Artioli, Grazia, Arver, Brita, Auber, Bernd, Azzollini, Jacopo, Balmana, Judith, Barkardottir, Rosa B., Barnes, Daniel R., Barroso, Alicia, Barrowdale, Daniel, Belotti, Muriel, Benitez, Javier, Bertelsen, Brigitte, Blok, Marinus J., Bodrogi, Istvan, Bonadona, Valerie, Bonanni, Bernardo, Bondavalli, Davide, Boonen, Susanne E., Borde, Julika, Borg, Ake, Bradbury, Angela R., Brady, Angela, Brewer, Carole, Brunet, Joan, Buecher, Bruno, Buys, Saundra S., Cabezas-Camarero, Santiago, Caldes, Trinidad, Caliebe, Almuth, Caligo, Maria A., Calvello, Mariarosaria, Campbell, Ian G., Carnevali, Ileana, Carrasco, Estela, Chan, Tsun L., Chu, Annie T. W., Chung, Wendy K., Claes, Kathleen B. M., Cook, Jackie, Cortesi, Laura, Couch, Fergus J., Daly, Mary B., Damante, Giuseppe, Darder, Esther, Davidson, Rosemarie, de la Hoya, Miguel, Della Puppa, Lara, Dennis, Joe, Diez, Orland, Ding, Yuan Chun, Ditsch, Nina, Domchek, Susan M., Donaldson, Alan, Dworniczak, Bernd, Easton, Douglas F., Eccles, Diana M., Eeles, Rosalind A., Ehrencrona, Hans, Ejlertsen, Bent, Engel, Christoph, Evans, D. Gareth, Faivre, Laurence, Faust, Ulrike, Feliubadalo, Lidia, Foretova, Lenka, Fostira, Florentia, Fountzilas, George, Frost, Debra, Garcia-Barberan, Vanesa, Garre, Pilar, Gauthier-Villars, Marion, Geczi, Lajos, Gehrig, Andrea, Gerdes, Anne-Marie, Gesta, Paul, Giannini, Giuseppe, Glendon, Gord, Godwin, Andrew K., Goldgar, David E., Greene, Mark H., Gutierrez-Barrera, Angelica M., Hahnen, Eric, Hamann, Ute, Hauke, Jan, Herold, Natalie, Hogervorst, Frans B. L., Honisch, Ellen, Hopper, John L., Hulick, Peter J., Izatt, Louise, Jager, Agnes, James, Paul, Janavicius, Ramunas, Jensen, Uffe Birk, Jensen, Thomas Dyrso, Johannsson, Oskar Th, John, Esther M., Joseph, Vijai, Kang, Eunyoung, Kast, Karin, Kiiski, Johanna, I, Kim, Sung-Won, Kim, Zisun, Ko, Kwang-Pil, Konstantopoulou, Irene, Kramer, Gero, Krogh, Lotte, Kruse, Torben A., Kwong, Ava, Larsen, Mirjam, Lasset, Christine, Lautrup, Charlotte, Lazaro, Conxi, Lee, Jihyoun, Lee, Jong Won, Lee, Min Hyuk, Lemke, Johannes, Lesueur, Fabienne, Liljegren, Annelie, Lindblom, Annika, Llovet, Patricia, Lopez-Fernandez, Adria, Lopez-Perolio, Irene, Lorca, Victor, Loud, Jennifer T., Ma, Edmond S. K., Mai, Phuong L., Manoukian, Siranoush, Mari, Veronique, Martin, Lynn, Matricardi, Laura, Mebirouk, Noura, Medici, Veronica, Meijers-Heijboer, Hanne E. J., Meindl, Alfons, Mensenkamp, Arjen R., Miller, Clare, Gomes, Denise Molina, Montagna, Marco, Mooij, Thea M., Moserle, Lidia, Mouret-Fourme, Emmanuelle, Mulligan, Anna Marie, Nathanson, Katherine L., Navratilova, Marie, Nevanlinna, Heli, Niederacher, Dieter, Nielsen, Finn C. Cilius, Nikitina-Zake, Liene, Offit, Kenneth, Olah, Edith, Olopade, Olufunmilayo, I, Ong, Kai-Ren, Osorio, Ana, Ott, Claus-Eric, Palli, Domenico, Park, Sue K., Parsons, Michael T., Pedersen, Inge Sokilde, Peissel, Bernard, Peixoto, Ana, Perez-Segura, Pedro, Peterlongo, Paolo, Petersen, Annabeth Hogh, Porteous, Mary E., Angel Pujana, Miguel, Radice, Paolo, Ramser, Juliane, Rantala, Johanna, Rashid, Muhammad U., Rhiem, Kerstin, Rizzolo, Piera, Robson, Mark E., Rookus, Matti A., Rossing, Caroline M., Ruddy, Kathryn J., Santos, Catarina, Saule, Claire, Scarpitta, Rosa, Schmutzler, Rita K., Schuster, Helene, Senter, Leigha, Seynaeve, Caroline M., Shah, Payal D., Sharma, Priyanka, Shin, Vivian Y., Silvestri, Valentina, Simard, Jacques, Singer, Christian F., Skytte, Anne-Bine, Snape, Katie, Solano, Angela R., Soucy, Penny, Southey, Melissa C., Spurdle, Amanda B., Steele, Linda, Steinemann, Doris, Stoppa-Lyonnet, Dominique, Stradella, Agostina, Sunde, Lone, Sutter, Christian, Tan, Yen Y., Teixeira, Manuel R., Teo, Soo Hwang, Thomassen, Mads, Tibiletti, Maria Grazia, Tischkowitz, Marc, Tognazzo, Silvia, Toland, Amanda E., Tommasi, Stefania, Torres, Diana, Toss, Angela, Trainer, Alison H., Tung, Nadine, van Asperen, Christi J., van der Baan, Frederieke H., van der Kolk, Lizet E., van der Luijt, Rob B., van Hest, Liselotte P., Varesco, Liliana, Varon-Mateeva, Raymonda, Viel, Alessandra, Vierstrate, Jeroen, Villa, Roberta, von Wachenfeldt, Anna, Wagner, Philipp, Wang-Gohrke, Shan, Wappenschmidt, Barbara, Weitzel, Jeffrey N., Wieme, Greet, Yadav, Siddhartha, Yannoukakos, Drakoulis, Yoon, Sook-Yee, Zanzottera, Cristina, Zorn, Kristin K., D'Amico, Anthony, V, Freedman, Matthew L., Pomerantz, Mark M., Chenevix-Trench, Georgia, Antoniou, Antonis C., Neuhausen, Susan L., Ottini, Laura, Nielsen, Henriette Roed, Rebbeck, Timothy R., Patel, Vivek L., Busch, Evan L., Friebel, Tara M., Cronin, Angel, Leslie, Goska, McGuffog, Lesley, Adlard, Julian, Agata, Simona, Agnarsson, Bjarni A., Ahmed, Munaza, Aittomaki, Kristiina, Alducci, Elisa, Andrulis, Irene L., Arason, Adalgeir, Arnold, Norbert, Artioli, Grazia, Arver, Brita, Auber, Bernd, Azzollini, Jacopo, Balmana, Judith, Barkardottir, Rosa B., Barnes, Daniel R., Barroso, Alicia, Barrowdale, Daniel, Belotti, Muriel, Benitez, Javier, Bertelsen, Brigitte, Blok, Marinus J., Bodrogi, Istvan, Bonadona, Valerie, Bonanni, Bernardo, Bondavalli, Davide, Boonen, Susanne E., Borde, Julika, Borg, Ake, Bradbury, Angela R., Brady, Angela, Brewer, Carole, Brunet, Joan, Buecher, Bruno, Buys, Saundra S., Cabezas-Camarero, Santiago, Caldes, Trinidad, Caliebe, Almuth, Caligo, Maria A., Calvello, Mariarosaria, Campbell, Ian G., Carnevali, Ileana, Carrasco, Estela, Chan, Tsun L., Chu, Annie T. W., Chung, Wendy K., Claes, Kathleen B. M., Cook, Jackie, Cortesi, Laura, Couch, Fergus J., Daly, Mary B., Damante, Giuseppe, Darder, Esther, Davidson, Rosemarie, de la Hoya, Miguel, Della Puppa, Lara, Dennis, Joe, Diez, Orland, Ding, Yuan Chun, Ditsch, Nina, Domchek, Susan M., Donaldson, Alan, Dworniczak, Bernd, Easton, Douglas F., Eccles, Diana M., Eeles, Rosalind A., Ehrencrona, Hans, Ejlertsen, Bent, Engel, Christoph, Evans, D. Gareth, Faivre, Laurence, Faust, Ulrike, Feliubadalo, Lidia, Foretova, Lenka, Fostira, Florentia, Fountzilas, George, Frost, Debra, Garcia-Barberan, Vanesa, Garre, Pilar, Gauthier-Villars, Marion, Geczi, Lajos, Gehrig, Andrea, Gerdes, Anne-Marie, Gesta, Paul, Giannini, Giuseppe, Glendon, Gord, Godwin, Andrew K., Goldgar, David E., Greene, Mark H., Gutierrez-Barrera, Angelica M., Hahnen, Eric, Hamann, Ute, Hauke, Jan, Herold, Natalie, Hogervorst, Frans B. L., Honisch, Ellen, Hopper, John L., Hulick, Peter J., Izatt, Louise, Jager, Agnes, James, Paul, Janavicius, Ramunas, Jensen, Uffe Birk, Jensen, Thomas Dyrso, Johannsson, Oskar Th, John, Esther M., Joseph, Vijai, Kang, Eunyoung, Kast, Karin, Kiiski, Johanna, I, Kim, Sung-Won, Kim, Zisun, Ko, Kwang-Pil, Konstantopoulou, Irene, Kramer, Gero, Krogh, Lotte, Kruse, Torben A., Kwong, Ava, Larsen, Mirjam, Lasset, Christine, Lautrup, Charlotte, Lazaro, Conxi, Lee, Jihyoun, Lee, Jong Won, Lee, Min Hyuk, Lemke, Johannes, Lesueur, Fabienne, Liljegren, Annelie, Lindblom, Annika, Llovet, Patricia, Lopez-Fernandez, Adria, Lopez-Perolio, Irene, Lorca, Victor, Loud, Jennifer T., Ma, Edmond S. K., Mai, Phuong L., Manoukian, Siranoush, Mari, Veronique, Martin, Lynn, Matricardi, Laura, Mebirouk, Noura, Medici, Veronica, Meijers-Heijboer, Hanne E. J., Meindl, Alfons, Mensenkamp, Arjen R., Miller, Clare, Gomes, Denise Molina, Montagna, Marco, Mooij, Thea M., Moserle, Lidia, Mouret-Fourme, Emmanuelle, Mulligan, Anna Marie, Nathanson, Katherine L., Navratilova, Marie, Nevanlinna, Heli, Niederacher, Dieter, Nielsen, Finn C. Cilius, Nikitina-Zake, Liene, Offit, Kenneth, Olah, Edith, Olopade, Olufunmilayo, I, Ong, Kai-Ren, Osorio, Ana, Ott, Claus-Eric, Palli, Domenico, Park, Sue K., Parsons, Michael T., Pedersen, Inge Sokilde, Peissel, Bernard, Peixoto, Ana, Perez-Segura, Pedro, Peterlongo, Paolo, Petersen, Annabeth Hogh, Porteous, Mary E., Angel Pujana, Miguel, Radice, Paolo, Ramser, Juliane, Rantala, Johanna, Rashid, Muhammad U., Rhiem, Kerstin, Rizzolo, Piera, Robson, Mark E., Rookus, Matti A., Rossing, Caroline M., Ruddy, Kathryn J., Santos, Catarina, Saule, Claire, Scarpitta, Rosa, Schmutzler, Rita K., Schuster, Helene, Senter, Leigha, Seynaeve, Caroline M., Shah, Payal D., Sharma, Priyanka, Shin, Vivian Y., Silvestri, Valentina, Simard, Jacques, Singer, Christian F., Skytte, Anne-Bine, Snape, Katie, Solano, Angela R., Soucy, Penny, Southey, Melissa C., Spurdle, Amanda B., Steele, Linda, Steinemann, Doris, Stoppa-Lyonnet, Dominique, Stradella, Agostina, Sunde, Lone, Sutter, Christian, Tan, Yen Y., Teixeira, Manuel R., Teo, Soo Hwang, Thomassen, Mads, Tibiletti, Maria Grazia, Tischkowitz, Marc, Tognazzo, Silvia, Toland, Amanda E., Tommasi, Stefania, Torres, Diana, Toss, Angela, Trainer, Alison H., Tung, Nadine, van Asperen, Christi J., van der Baan, Frederieke H., van der Kolk, Lizet E., van der Luijt, Rob B., van Hest, Liselotte P., Varesco, Liliana, Varon-Mateeva, Raymonda, Viel, Alessandra, Vierstrate, Jeroen, Villa, Roberta, von Wachenfeldt, Anna, Wagner, Philipp, Wang-Gohrke, Shan, Wappenschmidt, Barbara, Weitzel, Jeffrey N., Wieme, Greet, Yadav, Siddhartha, Yannoukakos, Drakoulis, Yoon, Sook-Yee, Zanzottera, Cristina, Zorn, Kristin K., D'Amico, Anthony, V, Freedman, Matthew L., Pomerantz, Mark M., Chenevix-Trench, Georgia, Antoniou, Antonis C., Neuhausen, Susan L., Ottini, Laura, Nielsen, Henriette Roed, and Rebbeck, Timothy R.
- Abstract
Pathogenic sequence variants (PSV) in BRCA1 or BRCA2 (BRCA1/2) are associated with increased risk and severity of prostate cancer. Weevaluated whether PSVs inBRCA1/2 were associated with risk of overall prostate cancer or high grade (Gleason 8+) prostate cancer using an international sample of 65 BRCA1 and 171 BRCA2 male PSV carriers with prostate cancer, and 3,388 BRCA1 and 2,880 BRCA2 male PSV carriers without prostate cancer. PSVs in the 30 region of BRCA2 (c.7914+) were significantly associated with elevated risk of prostate cancer compared with reference bin c.1001c.7913 [HR = 1.78; 95% confidence interval (CI), 1.25-2.52; P = 0.001], as well as elevated risk of Gleason 8+ prostate cancer (HR = 3.11; 95% CI, 1.63-5.95; P = 0.001). c.756-c.1000 was also associated with elevated prostate cancer risk (HR = 2.83; 95% CI, 1.71-4.68; P = 0.00004) and elevated risk of Gleason 8+prostate cancer (HR = 4.95; 95% CI, 2.12-11.54; P = 0.0002). No genotype-phenotype associations were detected for PSVs in BRCA1. These results demonstrate that specific BRCA2 PSVs may be associated with elevated risk of developing aggressive prostate cancer. Significance: Aggressive prostate cancer risk in BRCA2 mutation carriers may vary according to the specific BRCA2 mutation inherited by the at-risk individual.
- Published
- 2020
44. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness
- Author
-
Patel, Vivek L, Busch, Evan L, Friebel, Tara M, Cronin, Angel, Leslie, Goska, McGuffog, Lesley, Adlard, Julian, Agata, Simona, Agnarsson, Bjarni A, Ahmed, Munaza, Aittomäki, Kristiina, Alducci, Elisa, Andrulis, Irene L, Arason, Adalgeir, Arnold, Norbert, Artioli, Grazia, Arver, Brita, Auber, Bernd, Azzollini, Jacopo, Balmaña, Judith, Barkardottir, Rosa B, Barnes, Daniel R, Barroso, Alicia, Barrowdale, Daniel, Belotti, Muriel, Benitez, Javier, Bertelsen, Birgitte, Blok, Marinus J, Bodrogi, Istvan, Bonadona, Valérie, Bonanni, Bernardo, Bondavalli, Davide, Boonen, Susanne E, Borde, Julika, Borg, Ake, Bradbury, Angela R, Brady, Angela, Brewer, Carole, Brunet, Joan, Buecher, Bruno, Buys, Saundra S, Cabezas-Camarero, Santiago, Caldés, Trinidad, Caliebe, Almuth, Caligo, Maria A, Calvello, Mariarosaria, Campbell, Ian G, Carnevali, Ileana, Carrasco, Estela, Chan, Tsun L, Chu, Annie T W, Chung, Wendy K, Claes, Kathleen B M, Collaborators, Gemo Study, Collaborators, Embrace, Cook, Jackie, Cortesi, Laura, Couch, Fergus J, Daly, Mary B, Damante, Giuseppe, Darder, Esther, Davidson, Rosemarie, de la Hoya, Miguel, Puppa, Lara Della, Dennis, Joe, Díez, Orland, Ding, Yuan Chun, Ditsch, Nina, Domchek, Susan M, Donaldson, Alan, Dworniczak, Bernd, Easton, Douglas F, Eccles, Diana M, Eeles, Rosalind A, Ehrencrona, Hans, Ejlertsen, Bent, Engel, Christoph, Evans, D Gareth, Faivre, Laurence, Faust, Ulrike, Feliubadaló, Lídia, Foretova, Lenka, Fostira, Florentia, Fountzilas, George, Frost, Debra, García-Barberán, Vanesa, Garre, Pilar, Gauthier-Villars, Marion, Géczi, Lajos, Gehrig, Andrea, Gerdes, Anne-Marie, Gesta, Paul, Giannini, Giuseppe, Glendon, Gord, Godwin, Andrew K, Goldgar, David E, Greene, Mark H, Gutierrez-Barrera, Angelica M, Hahnen, Eric, Hamann, Ute, Hauke, Jan, Herold, Natalie, Hogervorst, Frans B L, Honisch, Ellen, Hopper, John L, Hulick, Peter J, Investigators, KConFab, Investigators, Hebon, Izatt, Louise, Jager, Agnes, James, Paul, Janavicius, Ramunas, Jensen, Uffe Birk, Jensen, Thomas Dyrso, Johannsson, Oskar Th, John, Esther M, Joseph, Vijai, Kang, Eunyoung, Kast, Karin, Kiiski, Johanna I, Kim, Sung-Won, Kim, Zisun, Ko, Kwang-Pil, Konstantopoulou, Irene, Kramer, Gero, Krogh, Lotte, Kruse, Torben A, Kwong, Ava, Larsen, Mirjam, Lasset, Christine, Lautrup, Charlotte, Lazaro, Conxi, Lee, Jihyoun, Lee, Jong Won, Lee, Min Hyuk, Lemke, Johannes, Lesueur, Fabienne, Liljegren, Annelie, Lindblom, Annika, Llovet, Patricia, Lopez-Fernández, Adria, Lopez-Perolio, Irene, Lorca, Victor, Loud, Jennifer T, Ma, Edmond S K, Mai, Phuong L, Manoukian, Siranoush, Mari, Veronique, Martin, Lynn, Matricardi, Laura, Mebirouk, Noura, Medici, Veronica, Meijers-Heijboer, Hanne E J, Meindl, Alfons, Mensenkamp, Arjen R, Miller, Clare, Gomes, Denise Molina, Montagna, Marco, Mooij, Thea M, Moserle, Lidia, Mouret-Fourme, Emmanuelle, Mulligan, Anna Marie, Nathanson, Katherine L, Navratilova, Marie, Nevanlinna, Heli, Niederacher, Dieter, Nielsen, Finn C Cilius, Nikitina-Zake, Liene, Offit, Kenneth, Olah, Edith, Olopade, Olufunmilayo I, Ong, Kai-Ren, Osorio, Ana, Ott, Claus-Eric, Palli, Domenico, Park, Sue K, Parsons, Michael T, Pedersen, Inge Sokilde, Peissel, Bernard, Peixoto, Ana, Pérez-Segura, Pedro, Peterlongo, Paolo, Petersen, Annabeth Høgh, Porteous, Mary E, Pujana, Miguel Angel, Radice, Paolo, Ramser, Juliane, Rantala, Johanna, Rashid, Muhammad U, Rhiem, Kerstin, Rizzolo, Piera, Robson, Mark E, Rookus, Matti A, Rossing, Caroline M, Ruddy, Kathryn J, Santos, Catarina, Saule, Claire, Scarpitta, Rosa, Schmutzler, Rita K, Schuster, Hélène, Senter, Leigha, Seynaeve, Caroline M, Shah, Payal D, Sharma, Priyanka, Shin, Vivian Y, Silvestri, Valentina, Simard, Jacques, Singer, Christian F, Skytte, Anne-Bine, Snape, Katie, Solano, Angela R, Soucy, Penny, Southey, Melissa C, Spurdle, Amanda B, Steele, Linda, Steinemann, Doris, Stoppa-Lyonnet, Dominique, Stradella, Agostina, Sunde, Lone, Sutter, Christian, Tan, Yen Y, Teixeira, Manuel R, Teo, Soo Hwang, Thomassen, Mads, Tibiletti, Maria Grazia, Tischkowitz, Marc, Tognazzo, Silvia, Toland, Amanda E, Tommasi, Stefania, Torres, Diana, Toss, Angela, Trainer, Alison H, Tung, Nadine, van Asperen, Christi J, van der Baan, Frederieke H, van der Kolk, Lizet E, van der Luijt, Rob B, van Hest, Liselotte P, Varesco, Liliana, Varon-Mateeva, Raymonda, Viel, Alessandra, Vierstraete, Jeroen, Villa, Roberta, von Wachenfeldt, Anna, Wagner, Philipp, Wang-Gohrke, Shan, Wappenschmidt, Barbara, Weitzel, Jeffrey N, Wieme, Greet, Yadav, Siddhartha, Yannoukakos, Drakoulis, Yoon, Sook-Yee, Zanzottera, Cristina, Zorn, Kristin K, D'Amico, Anthony V, Freedman, Matthew L, Pomerantz, Mark M, Chenevix-Trench, Georgia, Antoniou, Antonis C, Neuhausen, Susan L, Ottini, Laura, Nielsen, Henriette Roed, Rebbeck, Timothy R, Patel, Vivek L, Busch, Evan L, Friebel, Tara M, Cronin, Angel, Leslie, Goska, McGuffog, Lesley, Adlard, Julian, Agata, Simona, Agnarsson, Bjarni A, Ahmed, Munaza, Aittomäki, Kristiina, Alducci, Elisa, Andrulis, Irene L, Arason, Adalgeir, Arnold, Norbert, Artioli, Grazia, Arver, Brita, Auber, Bernd, Azzollini, Jacopo, Balmaña, Judith, Barkardottir, Rosa B, Barnes, Daniel R, Barroso, Alicia, Barrowdale, Daniel, Belotti, Muriel, Benitez, Javier, Bertelsen, Birgitte, Blok, Marinus J, Bodrogi, Istvan, Bonadona, Valérie, Bonanni, Bernardo, Bondavalli, Davide, Boonen, Susanne E, Borde, Julika, Borg, Ake, Bradbury, Angela R, Brady, Angela, Brewer, Carole, Brunet, Joan, Buecher, Bruno, Buys, Saundra S, Cabezas-Camarero, Santiago, Caldés, Trinidad, Caliebe, Almuth, Caligo, Maria A, Calvello, Mariarosaria, Campbell, Ian G, Carnevali, Ileana, Carrasco, Estela, Chan, Tsun L, Chu, Annie T W, Chung, Wendy K, Claes, Kathleen B M, Collaborators, Gemo Study, Collaborators, Embrace, Cook, Jackie, Cortesi, Laura, Couch, Fergus J, Daly, Mary B, Damante, Giuseppe, Darder, Esther, Davidson, Rosemarie, de la Hoya, Miguel, Puppa, Lara Della, Dennis, Joe, Díez, Orland, Ding, Yuan Chun, Ditsch, Nina, Domchek, Susan M, Donaldson, Alan, Dworniczak, Bernd, Easton, Douglas F, Eccles, Diana M, Eeles, Rosalind A, Ehrencrona, Hans, Ejlertsen, Bent, Engel, Christoph, Evans, D Gareth, Faivre, Laurence, Faust, Ulrike, Feliubadaló, Lídia, Foretova, Lenka, Fostira, Florentia, Fountzilas, George, Frost, Debra, García-Barberán, Vanesa, Garre, Pilar, Gauthier-Villars, Marion, Géczi, Lajos, Gehrig, Andrea, Gerdes, Anne-Marie, Gesta, Paul, Giannini, Giuseppe, Glendon, Gord, Godwin, Andrew K, Goldgar, David E, Greene, Mark H, Gutierrez-Barrera, Angelica M, Hahnen, Eric, Hamann, Ute, Hauke, Jan, Herold, Natalie, Hogervorst, Frans B L, Honisch, Ellen, Hopper, John L, Hulick, Peter J, Investigators, KConFab, Investigators, Hebon, Izatt, Louise, Jager, Agnes, James, Paul, Janavicius, Ramunas, Jensen, Uffe Birk, Jensen, Thomas Dyrso, Johannsson, Oskar Th, John, Esther M, Joseph, Vijai, Kang, Eunyoung, Kast, Karin, Kiiski, Johanna I, Kim, Sung-Won, Kim, Zisun, Ko, Kwang-Pil, Konstantopoulou, Irene, Kramer, Gero, Krogh, Lotte, Kruse, Torben A, Kwong, Ava, Larsen, Mirjam, Lasset, Christine, Lautrup, Charlotte, Lazaro, Conxi, Lee, Jihyoun, Lee, Jong Won, Lee, Min Hyuk, Lemke, Johannes, Lesueur, Fabienne, Liljegren, Annelie, Lindblom, Annika, Llovet, Patricia, Lopez-Fernández, Adria, Lopez-Perolio, Irene, Lorca, Victor, Loud, Jennifer T, Ma, Edmond S K, Mai, Phuong L, Manoukian, Siranoush, Mari, Veronique, Martin, Lynn, Matricardi, Laura, Mebirouk, Noura, Medici, Veronica, Meijers-Heijboer, Hanne E J, Meindl, Alfons, Mensenkamp, Arjen R, Miller, Clare, Gomes, Denise Molina, Montagna, Marco, Mooij, Thea M, Moserle, Lidia, Mouret-Fourme, Emmanuelle, Mulligan, Anna Marie, Nathanson, Katherine L, Navratilova, Marie, Nevanlinna, Heli, Niederacher, Dieter, Nielsen, Finn C Cilius, Nikitina-Zake, Liene, Offit, Kenneth, Olah, Edith, Olopade, Olufunmilayo I, Ong, Kai-Ren, Osorio, Ana, Ott, Claus-Eric, Palli, Domenico, Park, Sue K, Parsons, Michael T, Pedersen, Inge Sokilde, Peissel, Bernard, Peixoto, Ana, Pérez-Segura, Pedro, Peterlongo, Paolo, Petersen, Annabeth Høgh, Porteous, Mary E, Pujana, Miguel Angel, Radice, Paolo, Ramser, Juliane, Rantala, Johanna, Rashid, Muhammad U, Rhiem, Kerstin, Rizzolo, Piera, Robson, Mark E, Rookus, Matti A, Rossing, Caroline M, Ruddy, Kathryn J, Santos, Catarina, Saule, Claire, Scarpitta, Rosa, Schmutzler, Rita K, Schuster, Hélène, Senter, Leigha, Seynaeve, Caroline M, Shah, Payal D, Sharma, Priyanka, Shin, Vivian Y, Silvestri, Valentina, Simard, Jacques, Singer, Christian F, Skytte, Anne-Bine, Snape, Katie, Solano, Angela R, Soucy, Penny, Southey, Melissa C, Spurdle, Amanda B, Steele, Linda, Steinemann, Doris, Stoppa-Lyonnet, Dominique, Stradella, Agostina, Sunde, Lone, Sutter, Christian, Tan, Yen Y, Teixeira, Manuel R, Teo, Soo Hwang, Thomassen, Mads, Tibiletti, Maria Grazia, Tischkowitz, Marc, Tognazzo, Silvia, Toland, Amanda E, Tommasi, Stefania, Torres, Diana, Toss, Angela, Trainer, Alison H, Tung, Nadine, van Asperen, Christi J, van der Baan, Frederieke H, van der Kolk, Lizet E, van der Luijt, Rob B, van Hest, Liselotte P, Varesco, Liliana, Varon-Mateeva, Raymonda, Viel, Alessandra, Vierstraete, Jeroen, Villa, Roberta, von Wachenfeldt, Anna, Wagner, Philipp, Wang-Gohrke, Shan, Wappenschmidt, Barbara, Weitzel, Jeffrey N, Wieme, Greet, Yadav, Siddhartha, Yannoukakos, Drakoulis, Yoon, Sook-Yee, Zanzottera, Cristina, Zorn, Kristin K, D'Amico, Anthony V, Freedman, Matthew L, Pomerantz, Mark M, Chenevix-Trench, Georgia, Antoniou, Antonis C, Neuhausen, Susan L, Ottini, Laura, Nielsen, Henriette Roed, and Rebbeck, Timothy R
- Abstract
Pathogenic sequence variants (PSV) in BRCA1 or BRCA2 (BRCA1/2) are associated with increased risk and severity of prostate cancer. We evaluated whether PSVs in BRCA1/2 were associated with risk of overall prostate cancer or high grade (Gleason 8+) prostate cancer using an international sample of 65 BRCA1 and 171 BRCA2 male PSV carriers with prostate cancer, and 3,388 BRCA1 and 2,880 BRCA2 male PSV carriers without prostate cancer. PSVs in the 3' region of BRCA2 (c.7914+) were significantly associated with elevated risk of prostate cancer compared with reference bin c.1001-c.7913 [HR = 1.78; 95% confidence interval (CI), 1.25-2.52; P = 0.001], as well as elevated risk of Gleason 8+ prostate cancer (HR = 3.11; 95% CI, 1.63-5.95; P = 0.001). c.756-c.1000 was also associated with elevated prostate cancer risk (HR = 2.83; 95% CI, 1.71-4.68; P = 0.00004) and elevated risk of Gleason 8+ prostate cancer (HR = 4.95; 95% CI, 2.12-11.54; P = 0.0002). No genotype-phenotype associations were detected for PSVs in BRCA1. These results demonstrate that specific BRCA2 PSVs may be associated with elevated risk of developing aggressive prostate cancer. SIGNIFICANCE: Aggressive prostate cancer risk in BRCA2 mutation carriers may vary according to the specific BRCA2 mutation inherited by the at-risk individual.
- Published
- 2020
45. Efficacy of Risk-Reducing Salpingo-Oophorectomy in Women with BRCA-1 and BRCA-2 Mutations
- Author
-
Olopade, Olufunmilayo I. and Artioli, Grazia
- Published
- 2004
46. First line chemotherapy with Carboplatin plus Vinorelbine as treatment of head and neck and/or esophageal cancer in elderly or poor performance status (P.S.) patients.
- Author
-
Koussis, Haralabos, Sileni, Vanna Chiarion, Scola, Anna, Artioli, Grazia, Martinez-Monche, Gonzalo, Friso, Maria Luisa, Bottin, Raffaele, Andretta, Marilisa, Ruol, Alberto, and Monfardini, Silvio
- Published
- 2001
47. HYSTEROSCOPY IN TAMOXIFEN TREATED BREAST CANCER PATIENTS.
- Author
-
Nicoletto, Ornella, Mozzanega, Bruno, Marchesoni, Diego, Ghiotto, Cristina, Koussis, Haralabos, Beda, Manuela, Artioli, Grazia, Monfardini, Silvio, and Ambrosini, Antonio
- Published
- 2001
48. A PHASE I STUDY OF WEEKLY OXALIPLATIN (OXA) + CONTINUOUS INFUSION (CI) FLUOROURACIL (5-FU) IN PATIENTS WITH ADVANCED COLORECTAL CANCER (CCR)
- Author
-
Sartor, Lucia, Lonardi, Sara, Perin, Alessandra, Chiarion, Vanna Sileni, Artioli, Grazia, Monfardini, Silvio, and Aschele, Carlo
- Published
- 2001
49. A PHASE II STUDY OF LEUCOVORIN(LV)-MODULATED CONTINUOUS INFUSION (CI) FLUOROURACIL (FU) + CPT-11 ALTERNATING WITH LV-MODULATED CI FU + OXALIPLATIN (L-OHP) IN ADVANCED COLORECTAL CANCER: HIGH ACTIVITY AND LOW TOXICITY
- Author
-
Aschele, Carlo, Lonardi, Sara, Sartor, Lucia, Perin, Alessandra, Koussis, Babis, Artioli, Grazia, Ghiotto, Cristina, and Monfardini, Silvio
- Published
- 2001
50. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness
- Author
-
Patel, Vivek L., primary, Busch, Evan L., additional, Friebel, Tara M., additional, Cronin, Angel, additional, Leslie, Goska, additional, McGuffog, Lesley, additional, Adlard, Julian, additional, Agata, Simona, additional, Agnarsson, Bjarni A., additional, Ahmed, Munaza, additional, Aittomäki, Kristiina, additional, Alducci, Elisa, additional, Andrulis, Irene L., additional, Arason, Adalgeir, additional, Arnold, Norbert, additional, Artioli, Grazia, additional, Arver, Brita, additional, Auber, Bernd, additional, Azzollini, Jacopo, additional, Balmaña, Judith, additional, Barkardottir, Rosa B., additional, Barnes, Daniel R., additional, Barroso, Alicia, additional, Barrowdale, Daniel, additional, Belotti, Muriel, additional, Benitez, Javier, additional, Bertelsen, Birgitte, additional, Blok, Marinus J., additional, Bodrogi, Istvan, additional, Bonadona, Valérie, additional, Bonanni, Bernardo, additional, Bondavalli, Davide, additional, Boonen, Susanne E., additional, Borde, Julika, additional, Borg, Ake, additional, Bradbury, Angela R., additional, Brady, Angela, additional, Brewer, Carole, additional, Brunet, Joan, additional, Buecher, Bruno, additional, Buys, Saundra S., additional, Cabezas-Camarero, Santiago, additional, Caldés, Trinidad, additional, Caliebe, Almuth, additional, Caligo, Maria A., additional, Calvello, Mariarosaria, additional, Campbell, Ian G., additional, Carnevali, Ileana, additional, Carrasco, Estela, additional, Chan, Tsun L., additional, Chu, Annie T.W., additional, Chung, Wendy K., additional, Claes, Kathleen B.M., additional, Collaborators, GEMO Study, additional, Collaborators, EMBRACE, additional, Cook, Jackie, additional, Cortesi, Laura, additional, Couch, Fergus J., additional, Daly, Mary B., additional, Damante, Giuseppe, additional, Darder, Esther, additional, Davidson, Rosemarie, additional, de la Hoya, Miguel, additional, Puppa, Lara Della, additional, Dennis, Joe, additional, Díez, Orland, additional, Ding, Yuan Chun, additional, Ditsch, Nina, additional, Domchek, Susan M., additional, Donaldson, Alan, additional, Dworniczak, Bernd, additional, Easton, Douglas F., additional, Eccles, Diana M., additional, Eeles, Rosalind A., additional, Ehrencrona, Hans, additional, Ejlertsen, Bent, additional, Engel, Christoph, additional, Evans, D. Gareth, additional, Faivre, Laurence, additional, Faust, Ulrike, additional, Feliubadaló, Lídia, additional, Foretova, Lenka, additional, Fostira, Florentia, additional, Fountzilas, George, additional, Frost, Debra, additional, García-Barberán, Vanesa, additional, Garre, Pilar, additional, Gauthier-Villars, Marion, additional, Géczi, Lajos, additional, Gehrig, Andrea, additional, Gerdes, Anne-Marie, additional, Gesta, Paul, additional, Giannini, Giuseppe, additional, Glendon, Gord, additional, Godwin, Andrew K., additional, Goldgar, David E., additional, Greene, Mark H., additional, Gutierrez-Barrera, Angelica M., additional, Hahnen, Eric, additional, Hamann, Ute, additional, Hauke, Jan, additional, Herold, Natalie, additional, Hogervorst, Frans B.L., additional, Honisch, Ellen, additional, Hopper, John L., additional, Hulick, Peter J., additional, Investigators, KConFab, additional, Investigators, HEBON, additional, Izatt, Louise, additional, Jager, Agnes, additional, James, Paul, additional, Janavicius, Ramunas, additional, Jensen, Uffe Birk, additional, Jensen, Thomas Dyrso, additional, Johannsson, Oskar Th., additional, John, Esther M., additional, Joseph, Vijai, additional, Kang, Eunyoung, additional, Kast, Karin, additional, Kiiski, Johanna I., additional, Kim, Sung-Won, additional, Kim, Zisun, additional, Ko, Kwang-Pil, additional, Konstantopoulou, Irene, additional, Kramer, Gero, additional, Krogh, Lotte, additional, Kruse, Torben A., additional, Kwong, Ava, additional, Larsen, Mirjam, additional, Lasset, Christine, additional, Lautrup, Charlotte, additional, Lazaro, Conxi, additional, Lee, Jihyoun, additional, Lee, Jong Won, additional, Lee, Min Hyuk, additional, Lemke, Johannes, additional, Lesueur, Fabienne, additional, Liljegren, Annelie, additional, Lindblom, Annika, additional, Llovet, Patricia, additional, Lopez-Fernández, Adria, additional, Lopez-Perolio, Irene, additional, Lorca, Victor, additional, Loud, Jennifer T., additional, Ma, Edmond S.K., additional, Mai, Phuong L., additional, Manoukian, Siranoush, additional, Mari, Veronique, additional, Martin, Lynn, additional, Matricardi, Laura, additional, Mebirouk, Noura, additional, Medici, Veronica, additional, Meijers-Heijboer, Hanne E.J., additional, Meindl, Alfons, additional, Mensenkamp, Arjen R., additional, Miller, Clare, additional, Gomes, Denise Molina, additional, Montagna, Marco, additional, Mooij, Thea M., additional, Moserle, Lidia, additional, Mouret-Fourme, Emmanuelle, additional, Mulligan, Anna Marie, additional, Nathanson, Katherine L., additional, Navratilova, Marie, additional, Nevanlinna, Heli, additional, Niederacher, Dieter, additional, Nielsen, Finn C. Cilius, additional, Nikitina-Zake, Liene, additional, Offit, Kenneth, additional, Olah, Edith, additional, Olopade, Olufunmilayo I., additional, Ong, Kai-Ren, additional, Osorio, Ana, additional, Ott, Claus-Eric, additional, Palli, Domenico, additional, Park, Sue K., additional, Parsons, Michael T., additional, Pedersen, Inge Sokilde, additional, Peissel, Bernard, additional, Peixoto, Ana, additional, Pérez-Segura, Pedro, additional, Peterlongo, Paolo, additional, Petersen, Annabeth Høgh, additional, Porteous, Mary E., additional, Pujana, Miguel Angel, additional, Radice, Paolo, additional, Ramser, Juliane, additional, Rantala, Johanna, additional, Rashid, Muhammad U., additional, Rhiem, Kerstin, additional, Rizzolo, Piera, additional, Robson, Mark E., additional, Rookus, Matti A., additional, Rossing, Caroline M., additional, Ruddy, Kathryn J., additional, Santos, Catarina, additional, Saule, Claire, additional, Scarpitta, Rosa, additional, Schmutzler, Rita K., additional, Schuster, Hélène, additional, Senter, Leigha, additional, Seynaeve, Caroline M., additional, Shah, Payal D., additional, Sharma, Priyanka, additional, Shin, Vivian Y., additional, Silvestri, Valentina, additional, Simard, Jacques, additional, Singer, Christian F., additional, Skytte, Anne-Bine, additional, Snape, Katie, additional, Solano, Angela R., additional, Soucy, Penny, additional, Southey, Melissa C., additional, Spurdle, Amanda B., additional, Steele, Linda, additional, Steinemann, Doris, additional, Stoppa-Lyonnet, Dominique, additional, Stradella, Agostina, additional, Sunde, Lone, additional, Sutter, Christian, additional, Tan, Yen Y., additional, Teixeira, Manuel R., additional, Teo, Soo Hwang, additional, Thomassen, Mads, additional, Tibiletti, Maria Grazia, additional, Tischkowitz, Marc, additional, Tognazzo, Silvia, additional, Toland, Amanda E., additional, Tommasi, Stefania, additional, Torres, Diana, additional, Toss, Angela, additional, Trainer, Alison H., additional, Tung, Nadine, additional, van Asperen, Christi J., additional, van der Baan, Frederieke H., additional, van der Kolk, Lizet E., additional, van der Luijt, Rob B., additional, van Hest, Liselotte P., additional, Varesco, Liliana, additional, Varon-Mateeva, Raymonda, additional, Viel, Alessandra, additional, Vierstraete, Jeroen, additional, Villa, Roberta, additional, von Wachenfeldt, Anna, additional, Wagner, Philipp, additional, Wang-Gohrke, Shan, additional, Wappenschmidt, Barbara, additional, Weitzel, Jeffrey N., additional, Wieme, Greet, additional, Yadav, Siddhartha, additional, Yannoukakos, Drakoulis, additional, Yoon, Sook-Yee, additional, Zanzottera, Cristina, additional, Zorn, Kristin K., additional, D'Amico, Anthony V., additional, Freedman, Matthew L., additional, Pomerantz, Mark M., additional, Chenevix-Trench, Georgia, additional, Antoniou, Antonis C., additional, Neuhausen, Susan L., additional, Ottini, Laura, additional, Nielsen, Henriette Roed, additional, and Rebbeck, Timothy R., additional
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.